SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001308179-16-000395
Filing Date
2016-05-20
Accepted
2016-05-20 16:30:01
Documents
11
Period of Report
2016-05-20
Effectiveness Date
2016-05-20

Document Format Files

Seq Description Document Type Size
1 AKORN INC - DEF 14A lakr2016_def14a.htm DEF 14A 696037
2 GRAPHIC bullet.jpg GRAPHIC 1120
3 GRAPHIC check.jpg GRAPHIC 1301
4 GRAPHIC lakrx1x1.jpg GRAPHIC 14261
5 GRAPHIC lakrx4x1.jpg GRAPHIC 35276
6 GRAPHIC lakrx6x1.jpg GRAPHIC 16715
7 GRAPHIC lakrx25x1.jpg GRAPHIC 135765
8 GRAPHIC lakrx30x1.jpg GRAPHIC 57019
9 GRAPHIC proxycard1.jpg GRAPHIC 273098
10 GRAPHIC proxycard2.jpg GRAPHIC 273136
11 GRAPHIC uncheck.jpg GRAPHIC 1167
  Complete submission text file 0001308179-16-000395.txt   1812383
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32360 | Film No.: 161666520
SIC: 2834 Pharmaceutical Preparations